DON’T MISS
IamExpat FairIamExpat Job BoardIamExpat Webinars
Newsletters
EXPAT INFO
CAREER
HOUSING
EDUCATION
LIFESTYLE
EXPAT SERVICES
NEWS & ARTICLES
Home
Expat Info
German news & articles
BioNTech launches coronavirus vaccine trial for young children
Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy

BioNTech launches coronavirus vaccine trial for young children

Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy
or
follow us for regular updates:



Related Stories

Dating sites & Dating apps in GermanyDating sites & Dating apps in Germany
When will I get my coronavirus vaccination in Germany?When will I get my coronavirus vaccination in Germany?
Second Omicron booster jab gets green light from European Medicines AgencySecond Omicron booster jab gets green light from European Medicines Agency
July 2022: 15 changes affecting expats in GermanyJuly 2022: 15 changes affecting expats in Germany
STIKO recommends boosters for 12 - 17-year-olds in GermanySTIKO recommends boosters for 12 - 17-year-olds in Germany
Germany hopes new Novavax COVID jab might convince vaccine scepticsGermany hopes new Novavax COVID jab might convince vaccine sceptics
COVID vaccinations for 5 to 11-year-olds to start this week in GermanyCOVID vaccinations for 5 to 11-year-olds to start this week in Germany
December 2021: 9 changes affecting expats in GermanyDecember 2021: 9 changes affecting expats in Germany
For expats of all colours, shapes and sizes

Explore
Expat infoCareerHousingEducationLifestyleExpat servicesNews & articles
About us
IamExpat MediaAdvertisePost a jobContact usImpressumSitemap
More IamExpat
IamExpat Job BoardIamExpat HousingIamExpat FairWebinarsNewsletters
Privacy
Terms of usePrivacy policyCookiesAvoiding scams

Never miss a thing!Sign up for expat events, news & offers, delivered once a week.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy


© 2025 IamExpat Media B.V.
© 2025 IamExpat Media B.V.
Mar 27, 2021
Abi Carter

Editor in chief at IamExpat Media

Abi studied German and History at the University of Manchester and has since lived in Berlin, Hamburg and Utrecht, working since 2017 as a writer, editor and content marketeer. Although she's happily taken on some German and Dutch quirks, she keeps a stash of Yorkshire Tea on hand, because nowhere does a brew quite like home.Read more

So far, the effectiveness of the BioNTech / Pfizer vaccine against COVID-19 has only been tested on adults. After an initial test run on teenagers, the pharmaceutical companies are now investigating the safety and efficacy of their vaccine on significantly younger people. 

Pfizer / BioNTech start clinical trial involving young children

The Mainz-based company BioNTech and its US partner Pfizer will now join competitors Moderna and AstraZeneca to begin testing its coronavirus vaccine on younger children. “Together with our partner BioNTech, we have administered a dose to the first healthy children in a global ongoing phase 1 / 2 / 3 study,” Pfizer said in a statement on Friday. 

The purpose of the trial is to investigate how safe, tolerable and effective the shot is in children aged between six months and 11 years of age. They will test three different dosages on a cohort of around 4.500 children, to see which is the most effective among younger patients. Previously, the company tested its mRNA vaccine on adolescents aged between 12 and 15. 

Vaccine could be rolled out to children early next year

“We are proud to conduct this much-needed study for children and families eagerly awaiting a potential vaccination option,” said Pfizer. They added that they were hoping that the vaccine could be rolled out to younger age groups from the beginning of next year. 

Children are generally spared from severe courses of COVID-19, but there have been isolated cases of serious infections and even deaths. Despite earlier hypotheses to the contrary, there is also a growing batch of evidence suggesting that children can be carriers of the virus. In order to achieve herd immunity, therefore, it may be necessary to also vaccinate children. 

By Abi Carter